Oramed Issues Letter to Shareholders with Updates on Oral Insulin and COVID-19 Vaccine
– Phase 3 Studies of Oral Insulin Underway and on Schedule – Oral COVID-19 Vaccine Clinical Trials Through Oravax Medical to Begin H2 2021 NEW YORK, May 25, 2021 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, is pleased to provide […]
